The future of immune checkpoint blockade immunotherapy: towards personalized therapy or towards combination therapy
J Thorac Dis
.
2017 Nov;9(11):4226-4229.
doi: 10.21037/jtd.2017.10.31.
Author
Zhiwei Hu
1
Affiliation
1
Department of Surgery Division of Surgical Oncology, The Ohio State University College of Medicine, James Comprehensive Cancer Center, Columbus, OH, USA.
PMID:
29268478
PMCID:
PMC5721014
DOI:
10.21037/jtd.2017.10.31
No abstract available
Publication types
Editorial
Comment
Grants and funding
R21 CA216697/CA/NCI NIH HHS/United States
UL1 TR001070/TR/NCATS NIH HHS/United States